|
|
| | PGPC-d6 Basic information |
| Product Name: | PGPC-d6 | | Synonyms: | PGPC-d6 | | CAS: | | | MF: | C29H50D6NO10P | | MW: | 615.766371668 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | PGPC-d6 Chemical Properties |
| solubility | DMSO: 1 mg/ml
Ethanol: 20 mg/mlPBS (pH 7.2): 5 mg/ml |
| | PGPC-d6 Usage And Synthesis |
| Description | PGPC-d6 is intended for use as an internal standard for the quantification of PGPC (Item No. 10044), as well as related fragmented short-chain fatty acid remnants of phospholipid oxidation, by GC- or LC-MS. PGPC is an oxidized phospholipid that can be formed under conditions of oxidative stress.1 It is found as a component in mildly oxidized LDL (MM-LDL) and in products formed from the oxidation of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (Ox-PAPC).2 PGPC activates peroxisome proliferator-activated receptor α (PPARα) in a concentration-dependent manner in a cell-based ligand-binding assay.3 It increases VCAM1 and E-selectin expression in human aortic endothelial cells (HAECs), as well as HAEC binding by monocytes and polymorphonuclear neutrophils (PMNs), in a concentration-dependent manner.4 PGPC (37.5 μM) also increases total 5-lipoxygenase metabolites in murine resident peritoneal macrophages (RPMs) and induces apoptosis in A7r5 rat aortic smooth muscle cells in vitro when used at a concentration of 50 μM.5,6 PGPC levels are increased in serum, LDL, and peripheral blood mononuclear cells (PBMCs) of patients with coronary artery disease.7 UVA irradiation increases PGPC levels in cultured human skin fibroblasts.8WARNING This product is not for human or veterinary use. | | References | [1] GILBERT O. FRUHWIRTH Albin H Alexandra Loidl. Oxidized phospholipids: From molecular properties to disease[J]. Biochimica et biophysica acta. Molecular basis of disease, 2007, 1772 7: Pages 718-736. DOI: 10.1016/j.bbadis.2007.04.009
[2] A D WATSON. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.[J]. The Journal of Biological Chemistry, 1997, 272 21: 13597-13607. DOI: 10.1074/jbc.272.21.13597
[3] H LEE. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells.[J]. Circulation research, 2000, 87 6: 516-521. DOI: 10.1161/01.res.87.6.516
[4] N LEITINGER. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96 21: 12010-12015. DOI: 10.1073/pnas.96.21.12010
[5] KARIN A. ZEMSKI BERRY Robert C M. Phospholipid Ozonation Products Activate the 5-Lipoxygenase Pathway in Macrophages[J]. Chemical Research in Toxicology, 2016, 29 8: 1355-1364. DOI: 10.1021/acs.chemrestox.6b00193
[6] GILBERT O. FRUHWIRTH . The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells[J]. Biochimica et biophysica acta. Molecular and cell biology of lipids, 2006, 1761 9: Pages 1060-1069. DOI: 10.1016/j.bbalip.2006.06.001
[7] C. MOZZINI. Increased endoplasmic reticulum stress and nrf2 repression in peripheral blood mononuclear cells of patients with stable coronary artery disease[J]. European Journal of Internal Medicine, 2013, 24: Page e36. DOI: 10.1016/j.ejim.2013.08.088
[8] FLORIAN GRUBER. A simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiation.[J]. Journal of Lipid Research, 2012: 1232-1242. DOI: 10.1194/jlr.d025270 |
| | PGPC-d6 Preparation Products And Raw materials |
|